drugset
drugset / Trial / NCT03013439

Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)

NCT03013439 ↗

Phase 1 Completed 24 enrolled Pharmacosmos A/S
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The trial is an open-label, 4 cohorts, sequential, dose-escalating, single dose trial.

Timeline

Start
2017-01-06
Primary completion
2017-06-04
Completion
2017-06-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron isomaltoside 1000 Unknown — —

Indications

iron deficiency anemia iron metabolism disease